Medical Device Cybersecurity Left Out of FDA Authorization Bill
The FDA's five-year authorization to collect fees from the healthcare sector for independent review of new drugs and medical devices is expiring with the fiscal year.
🔒 Members Only · Cyber & AI BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.